Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
29.37 USD | +0.20% | -2.55% | -9.07% |
04-30 | Harmony Biosciences Acquires Epygenix Therapeutics; Shares Rise | MT |
04-30 | Transcript : Harmony Biosciences Holdings, Inc., Q1 2024 Earnings Call, Apr 30, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.07% | 1.66B | |
+31.91% | 694B | |
+29.55% | 593B | |
-1.68% | 371B | |
+19.29% | 331B | |
+6.51% | 290B | |
+14.21% | 239B | |
-3.07% | 209B | |
+10.03% | 209B | |
+8.28% | 169B |
- Stock Market
- Equities
- HRMY Stock
- News Harmony Biosciences Holdings, Inc.
- Raymond James Adjusts Price Target on Harmony Biosciences to $27 From $26, Maintains Outperform Rating